balofloxacin has been researched along with E coli Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, XH; Li, H; Peng, XX; Zhang, BW | 1 |
| Fukuda, H; Irimajiri, S; Masuda, G; Nitta, Y; Obana, M; Sakamoto, Y; Takizawa, Y; Tomizawa, I; Tsunoda, T; Yamaguchi, T | 1 |
1 trial(s) available for balofloxacin and E coli Infections
| Article | Year |
|---|---|
[clinical study of balofloxacin on infectious enteritis and assessment of the fecal drug concentration and intestinal microbial flora in patients with inpatients with infectious enteritis. Research group of balofloxacin on infectious enteritis].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Drug Administration Schedule; Dysentery, Bacillary; Enteritis; Escherichia coli; Escherichia coli Infections; Feces; Female; Fluoroquinolones; Humans; Intestines; Male; Middle Aged; Quinolones; Salmonella; Shigella | 1995 |
1 other study(ies) available for balofloxacin and E coli Infections
| Article | Year |
|---|---|
Myo-inositol improves the host's ability to eliminate balofloxacin-resistant Escherichia coli.
Topics: Adaptation, Biological; Animals; Anti-Bacterial Agents; Biomarkers; Computational Biology; Disease Models, Animal; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Host-Pathogen Interactions; Inositol; Macrophages; Metabolomics; Mice; Models, Biological; Phagocytosis; Proteomics; Zebrafish | 2015 |